Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer worldwide
3.2.1.2 Technological advancements in molecular diagnostics
3.2.1.3 Growing demand for personalized medicine
3.2.1.4 Rising demand for point-of-care testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High cost of molecular diagnostics
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Reagents and kits
5.4 Other product types
Chapter 6 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Polymerase chain reaction (PCR)
6.3 Isothermal nucleic acid amplification technology (INAAT)
6.4 Sequencing
6.5 In-situ hybridization
6.6 Chips and microarrays
6.7 Mass spectrometry
6.8 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Breast cancer
7.3 Prostate cancer
7.4 Colorectal cancer
7.5 Cervical cancer
7.6 Liver cancer
7.7 Lung cancer
7.8 Blood cancer
7.9 Kidney cancer
7.10 Other applications
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic laboratories
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Agilent Technologies, Inc.
10.3 Becton, Dickinson and Company
10.4 Biocartis Group NV
10.5 bioMerieux S.A.
10.6 Bio-Rad Laboratories, Inc.
10.7 Danaher Corporation
10.8 F. Hoffmann La Roche Ltd.
10.9 Hologic, Inc.
10.10 Illumina, Inc.
10.11 QIAGEN N.V.
10.12 Siemens Healthineers AG
10.13 Sysmex Corporation
10.14 Thermo Fisher Scientific Inc.
